Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

DexCom, Inc.

NASDAQ

Market Cap.

50.65B

Avg. Volume

2.81M

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze DexCom, Inc.!

Still processing it, give me a bit more time...

DexCom, Inc. News

DexCom, Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Website screenshot
HealthcareMedical - Devices
dexcom.com

About DexCom, Inc.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

DexCom, Inc. Earnings & Revenue

DexCom, Inc. Financials

Table Compare

Compare DXCM metrics with:

   

Earnings & Growth

DXCM

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

DXCM

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

DXCM

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

DXCM

None

Debt Ratio

--

--

Quick Ratio

--

--

 

DexCom, Inc. Income

DexCom, Inc. Balance Sheet

DexCom, Inc. Cash Flow

DexCom, Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsNeutral
Return on EquityStrong Buy
Return on AssetsStrong Buy
Debt/Equity RatioStrong Buy
Price/Earnings RatioStrong Buy
Price/Book RatioStrong Buy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

DexCom, Inc. Executives

NameRole
Mr. Kevin Ronald SayerExecutive Chairman, Chief Executive Officer & President
Ms. Teri LawverExecutive Vice President & Chief Commercial Officer
Mr. Jacob Steven LeachExecutive Vice President & Chief Operating Officer
Mr. Michael Jon BrownExecutive Vice President & Chief Legal Officer
Mr. Jereme M. SylvainExecutive Vice President, Chief Financial Officer & Chief Accounting Officer
NameRoleGenderDate of BirthPay
Mr. Kevin Ronald SayerExecutive Chairman, Chief Executive Officer & PresidentMale19583.23M
Ms. Teri LawverExecutive Vice President & Chief Commercial OfficerFemale19671.41M
Mr. Jacob Steven LeachExecutive Vice President & Chief Operating OfficerMale19781.29M
Mr. Michael Jon BrownExecutive Vice President & Chief Legal OfficerMale19701.22M
Mr. Jereme M. SylvainExecutive Vice President, Chief Financial Officer & Chief Accounting OfficerMale19801.13M

DexCom, Inc. Insider Trades

Date22 May
NameTOPOL ERIC
RoleDirector
TransactionAcquired
TypeA-Award
Shares2618
Date22 May
NameMalady Kyle
RoleDirector
TransactionAcquired
TypeA-Award
Shares2613
Date22 May
NameHeller Bridgette P
RoleDirector
TransactionAcquired
TypeA-Award
Shares2618
Date22 May
NameFOLETTA MARK G
RoleDirector
TransactionAcquired
TypeA-Award
Shares2973
Date22 May
NameDriscoll Rimma
RoleDirector
TransactionAcquired
TypeA-Award
Shares2632
DateNameRoleTransactionTypeShares
22 MayTOPOL ERICDirectorAcquiredA-Award2618
22 MayMalady KyleDirectorAcquiredA-Award2613
22 MayHeller Bridgette PDirectorAcquiredA-Award2618
22 MayFOLETTA MARK GDirectorAcquiredA-Award2973
22 MayDriscoll RimmaDirectorAcquiredA-Award2632

Discover More

Streamlined Academy

DexCom, Inc.

NASDAQ

Market Cap.

50.65B

Avg. Volume

2.81M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

DexCom, Inc. News

DexCom, Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

DexCom, Inc. Earnings & Revenue

DexCom, Inc. Income

DexCom, Inc. Balance Sheet

DexCom, Inc. Cash Flow

DexCom, Inc. Financials Over Time

DexCom, Inc. Executives

NameRole
Mr. Kevin Ronald SayerExecutive Chairman, Chief Executive Officer & President
Ms. Teri LawverExecutive Vice President & Chief Commercial Officer
Mr. Jacob Steven LeachExecutive Vice President & Chief Operating Officer
Mr. Michael Jon BrownExecutive Vice President & Chief Legal Officer
Mr. Jereme M. SylvainExecutive Vice President, Chief Financial Officer & Chief Accounting Officer
NameRoleGenderDate of BirthPay
Mr. Kevin Ronald SayerExecutive Chairman, Chief Executive Officer & PresidentMale19583.23M
Ms. Teri LawverExecutive Vice President & Chief Commercial OfficerFemale19671.41M
Mr. Jacob Steven LeachExecutive Vice President & Chief Operating OfficerMale19781.29M
Mr. Michael Jon BrownExecutive Vice President & Chief Legal OfficerMale19701.22M
Mr. Jereme M. SylvainExecutive Vice President, Chief Financial Officer & Chief Accounting OfficerMale19801.13M

DexCom, Inc. Insider Trades

Date22 May
NameTOPOL ERIC
RoleDirector
TransactionAcquired
TypeA-Award
Shares2618
Date22 May
NameMalady Kyle
RoleDirector
TransactionAcquired
TypeA-Award
Shares2613
Date22 May
NameHeller Bridgette P
RoleDirector
TransactionAcquired
TypeA-Award
Shares2618
Date22 May
NameFOLETTA MARK G
RoleDirector
TransactionAcquired
TypeA-Award
Shares2973
Date22 May
NameDriscoll Rimma
RoleDirector
TransactionAcquired
TypeA-Award
Shares2632
DateNameRoleTransactionTypeShares
22 MayTOPOL ERICDirectorAcquiredA-Award2618
22 MayMalady KyleDirectorAcquiredA-Award2613
22 MayHeller Bridgette PDirectorAcquiredA-Award2618
22 MayFOLETTA MARK GDirectorAcquiredA-Award2973
22 MayDriscoll RimmaDirectorAcquiredA-Award2632

Streamlined Academy

Website screenshot
HealthcareMedical - Devices
dexcom.com

About DexCom, Inc.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze DexCom, Inc.!

Still processing it, give me a bit more time...

DexCom, Inc. Financials

Table Compare

Compare DXCM metrics with:

   

Earnings & Growth

DXCM

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

DXCM

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

DXCM

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

DXCM

None

Debt Ratio

--

--

Quick Ratio

--

--

 

DexCom, Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsNeutral
Return on EquityStrong Buy
Return on AssetsStrong Buy
Debt/Equity RatioStrong Buy
Price/Earnings RatioStrong Buy
Price/Book RatioStrong Buy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More